PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Phased formulations of ethinylestradiol
Presentation Product Chemical substance Chapter Items dispensed
Generic Logynon tablets
0703010P0AAAAAA
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders 1
Generic Binovum tablets
0703010P0AAABAB
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Generic Logynon ED tablets
0703010P0AAAEAE
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Generic Synphase tablets
0703010P0AAAFAF
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Generic Tri-Minulet tablets
0703010P0AAADAD
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available
Generic Trinovum tablets
0703010P0AAACAC
Phased formulations of ethinylestradiol Phased formulations of ethinylestradiol Obstetrics, Gynaecology and Urinary-Tract Disorders No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.